Automated description from the Alliance of Genome Resources (Release 8.3.0)
Predicted to enable guanyl-nucleotide exchange factor activity; phosphatidylinositol-3,4,5-trisphosphate binding activity; and phosphatidylinositol-3,5-bisphosphate binding activity. Predicted to be involved in several processes, including Golgi disassembly; Golgi vesicle transport; and protein localization to endoplasmic reticulum. Is active in Golgi apparatus. Is expressed in brain; embryo; and head. Human ortholog(s) of this gene implicated in Charcot-Marie-Tooth disease dominant intermediate A. Orthologous to human GBF1 (golgi brefeldin A resistant guanine nucleotide exchange factor 1).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.